Some evidence [8–10] suggests that resistin modulates glucose tolerance and insulin action, thereby playing a role in the pathogenesis of obesity and insulin resistance in humans. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.